Insider Transactions in Q1 2023 at Selecta Biosciences Inc (SELB)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2023
|
Peter G Traber Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,465
-0.39%
|
$3,465
$1.12 P/Share
|
|
Jan 05
2023
|
Takashi Kei Kishimoto Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,392
-0.46%
|
$3,392
$1.12 P/Share
|
|
Jan 05
2023
|
Lloyd P. Johnston Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,392
-0.63%
|
$3,392
$1.12 P/Share
|
|
Jan 05
2023
|
Carsten Brunn President and CEO |
SELL
Open market or private sale
|
Direct |
13,473
-0.84%
|
$13,473
$1.13 P/Share
|
|
Jan 04
2023
|
Peter G Traber Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,179
-0.89%
|
$8,179
$1.14 P/Share
|
|
Jan 04
2023
|
Takashi Kei Kishimoto Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,392
-0.85%
|
$6,392
$1.14 P/Share
|
|
Jan 04
2023
|
Lloyd P. Johnston Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
6,392
-1.16%
|
$6,392
$1.14 P/Share
|
|
Jan 04
2023
|
Carsten Brunn President and CEO |
SELL
Open market or private sale
|
Direct |
27,597
-1.67%
|
$27,597
$1.14 P/Share
|
|
Jan 02
2023
|
Takashi Kei Kishimoto Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+21.09%
|
-
|
|
Jan 02
2023
|
Lloyd P. Johnston Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+26.65%
|
-
|
|
Jan 02
2023
|
Carsten Brunn President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
282,800
+25.48%
|
-
|
|
Jan 02
2023
|
Peter G Traber Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+30.41%
|
-
|